Chronic Limb Threatening Ischemia clinical trials

Explore recruiting chronic limb threatening ischemia clinical trials.

Recruiting chronic limb threatening ischemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Limb Threatening Ischemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, FIRST-IN-HUMAN, PHASE 1B/2A STUDY TO EVALUATE SAFETY AND EFFICACY OF SINGLE-DOSE TRI-001 IN PATIENTS WITH CHRONIC LIMB THREATENING ISCHEMIA (CLTI) DUE TO PERIPHERAL ARTERIAL DISEASE (PAD)

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD

Italy, Belgium, Netherlands, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia after Distal Revascularization: a randomized, double-blind trial PALADIN [PeripherAL Arterial DIsease Network] -DAPTCLTI

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diabetic patients with chronic limb-threatening ischemia

Czechia

Phase II and Phase III (Integrated) EU CTIS Study details

Efficacy of combined treatment by autologous cell therapy and percutaneous transluminal angioplasty (PTA) versus the treatment by isolated PTA in diabetic patients with chronic limb-threatening ischemia

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 2a open-label study to assess the safety, tolerability, and dosing regimen of antithrombotic heparin proteoglycan mimetic APAC (antiplatelet, anticoagulant) in patients with peripheral arterial occlusive disease and chronic limb-threatening ischemia undergoing endovascular revascularization (HEALING -study)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Limb Threatening Ischemia trials by city

Chronic Limb Threatening Ischemia clinical trials

Recruiting chronic limb threatening ischemia studies right now

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Serrantor OCT Study

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Chronic Wounds and Blood Circulation Detection

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia

AcoArt Litos PCB Below-the-knee Global Trial

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Nutrition in Patient With Critical Limb Ischemia